MX362338B - Derivados biaromaticos antibacterianos. - Google Patents

Derivados biaromaticos antibacterianos.

Info

Publication number
MX362338B
MX362338B MX2015014576A MX2015014576A MX362338B MX 362338 B MX362338 B MX 362338B MX 2015014576 A MX2015014576 A MX 2015014576A MX 2015014576 A MX2015014576 A MX 2015014576A MX 362338 B MX362338 B MX 362338B
Authority
MX
Mexico
Prior art keywords
hydroxy
alkoxy
cyano
dotted line
oxoethoxy
Prior art date
Application number
MX2015014576A
Other languages
English (en)
Other versions
MX2015014576A (es
Inventor
Hubschwerlen Christian
Zumbrunn Cornelia
Rueedi Georg
Cren Sylvaine
Friedli Astrid
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of MX2015014576A publication Critical patent/MX2015014576A/es
Publication of MX362338B publication Critical patent/MX362338B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Abstract

La invención se refiere a compuestos antibacterianos de la fórmula I (I), en donde R es H, ciano, alcoxi, cianometoxi, cicloalquilmetoxi, hidroxialcoxi, alcoxialcoxi, alcoxicarbonilo, 2-etoxi- 2-oxoetoxi, 2-(metilam ino)-2-oxoetoxi, (1 -cianociclobutil)metoxi, 3-hidroxi-pirrolidin-1-ilo o 3,4-dihidroxiciclopentil)metoxi; U1 es N o CR1, U2 es N o CR2, U3 es N o CR3 y U4 es N o CR4, y se entiende que como máximo tres de U1, U2, U3 y U4 pueden ser N al mismo tiempo; V1 es N o CR5, V2 es N o CR6, V3 es N o CR7 y V4 es N o CH, y se entiende que como máximo dos de V1, V2, V3 y V4 pueden ser N al mismo tiempo; R1 es H, ciano, hidroxi o alcoxi; R2 es H, hidroxi o alcoxi; R3 es H, ciano, hidroxi, alcoxi o carboxamido; R4 es H o alcoxi; R5 es H, hidroxi o halógeno; R6 es H, hidroxi o halógeno; R7 es H; la línea de puntos "-----" representa un enlace o se encuentra ausente; W representa CH o N cuando la línea de puntos "-----" es un enlace, o W representa CH2 cuando la línea de puntos "-----" se encuentra ausente; X representa CH o N; y Q representa O u S; y sus sales.
MX2015014576A 2013-04-16 2014-04-15 Derivados biaromaticos antibacterianos. MX362338B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2013053021 2013-04-16
PCT/IB2014/060724 WO2014170821A1 (en) 2013-04-16 2014-04-15 Antibacterial biaromatic derivatives

Publications (2)

Publication Number Publication Date
MX2015014576A MX2015014576A (es) 2016-03-04
MX362338B true MX362338B (es) 2019-01-11

Family

ID=50639826

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014576A MX362338B (es) 2013-04-16 2014-04-15 Derivados biaromaticos antibacterianos.

Country Status (21)

Country Link
US (1) US9527867B2 (es)
EP (1) EP2986607B1 (es)
JP (1) JP6375365B2 (es)
KR (1) KR20150143720A (es)
CN (1) CN105143216B (es)
AR (1) AR095884A1 (es)
AU (1) AU2014255326B2 (es)
BR (1) BR112015026261A8 (es)
CA (1) CA2907832A1 (es)
CL (1) CL2015003019A1 (es)
EA (1) EA029361B1 (es)
ES (1) ES2640482T3 (es)
HK (1) HK1221459A1 (es)
MA (1) MA38588B1 (es)
MX (1) MX362338B (es)
PH (1) PH12015502411A1 (es)
PL (1) PL2986607T3 (es)
SA (1) SA515361261B1 (es)
SG (1) SG11201508479RA (es)
TW (1) TWI631119B (es)
WO (1) WO2014170821A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0920895A8 (pt) 2008-10-07 2017-12-26 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
AR102256A1 (es) * 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2017157885A1 (de) 2016-03-16 2017-09-21 Bayer Cropscience Aktiengesellschaft N-(cyanbenzyl)-6-(cyclopropylcarbonylamino)-4-(phenyl)-pyridin-2-carboxamid-derivate und verwandte verbindungen als pestizide pflanzenschutzmittel
AR108108A1 (es) 2016-04-14 2018-07-18 Idorsia Pharmaceuticals Ltd Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi
GB2550437B (en) * 2016-05-20 2021-06-23 Bugworks Res Inc Heterocyclic compounds useful as anti-bacterial agents and method for production
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
EP3284739A1 (de) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituierte (het)arylverbindungen als schädlingsbekämpfungsmittel
WO2019106693A1 (en) 2017-11-29 2019-06-06 Bugworks Research India Pvt Ltd Anti-bacterial heterocyclic compounds and their synthesis
EP3837263A1 (en) 2018-08-13 2021-06-23 F. Hoffmann-La Roche AG New heterocyclic compounds as monoacylglycerol lipase inhibitors
EP4028403B1 (en) 2019-09-12 2023-11-22 F. Hoffmann-La Roche AG 4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors
CN115298176A (zh) * 2020-03-24 2022-11-04 豪夫迈·罗氏有限公司 化合物以及它们在治疗细菌感染中的用途
CN115785718B (zh) * 2022-11-25 2023-08-22 四川大学 一种多基底表面的金属配位抗菌涂层及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297042A1 (de) 1987-06-23 1988-12-28 Ciba-Geigy Ag Substituierte Penem-Verbindungen
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
AU1026901A (en) 1999-10-29 2001-05-08 Syngenta Participations Ag Novel herbicides
WO2003043997A1 (en) 2001-11-15 2003-05-30 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
AR040335A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
US20090186834A1 (en) 2005-03-24 2009-07-23 Microbia, Inc. Diphenylheterocycle cholesterol absorption inhibitors
TW200734311A (en) 2005-11-21 2007-09-16 Astrazeneca Ab New compounds
US7998992B2 (en) 2007-03-30 2011-08-16 Institute Of Medicinal Molecular Design, Inc. Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
DK2231590T3 (da) 2007-12-20 2012-07-09 Pharma Mar Sa Antitumorforbindelser
MX2010008922A (es) 2008-02-20 2010-09-07 Actelion Pharmaceuticals Ltd Compuestos antibioticos azatriciclicos.
ES2398939T3 (es) 2008-02-22 2013-03-22 Actelion Pharmaceuticals Ltd. Derivados de oxazolidinona
MX2011000968A (es) * 2008-08-04 2011-03-02 Actelion Pharmaceuticals Ltd Derivados de alquilaminometiloxazolidinona triciclicos.
BRPI0920895A8 (pt) 2008-10-07 2017-12-26 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
CN102164915A (zh) * 2008-10-10 2011-08-24 埃科特莱茵药品有限公司 作为抗菌剂的2-苯并噻吩基-和2-萘基-噁唑烷酮及其氮杂等排体类似物
PL2776431T3 (pl) 2011-11-08 2016-11-30 Stanowiące antybiotyki pochodne 2-okso-oksazolidyno-3,5-diylu

Also Published As

Publication number Publication date
TWI631119B (zh) 2018-08-01
TW201516043A (zh) 2015-05-01
EP2986607B1 (en) 2017-06-14
WO2014170821A1 (en) 2014-10-23
CA2907832A1 (en) 2014-10-23
US20160075722A1 (en) 2016-03-17
KR20150143720A (ko) 2015-12-23
MA38588B1 (fr) 2018-04-30
PL2986607T3 (pl) 2017-11-30
CL2015003019A1 (es) 2016-09-30
CN105143216B (zh) 2018-04-13
BR112015026261A2 (pt) 2017-07-25
US9527867B2 (en) 2016-12-27
HK1221459A1 (zh) 2017-06-02
ES2640482T3 (es) 2017-11-03
JP6375365B2 (ja) 2018-08-15
CN105143216A (zh) 2015-12-09
AR095884A1 (es) 2015-11-18
SA515361261B1 (ar) 2016-06-15
SG11201508479RA (en) 2015-11-27
MX2015014576A (es) 2016-03-04
EP2986607A1 (en) 2016-02-24
EA029361B1 (ru) 2018-03-30
AU2014255326A1 (en) 2015-11-26
EA201501025A1 (ru) 2016-08-31
JP2016516805A (ja) 2016-06-09
AU2014255326B2 (en) 2018-09-13
MA38588A1 (fr) 2017-05-31
BR112015026261A8 (pt) 2017-12-26
PH12015502411A1 (en) 2016-02-22

Similar Documents

Publication Publication Date Title
PH12015502411A1 (en) Antibacterial biaromatic derivatives
CY1120066T1 (el) Ενωση κινολονης
EA201591429A1 (ru) 2,3-дизамещенные производные 1-ацил-4-амино-1,2,3,4-тетрагидрохинолинов и их применение в качестве ингибиторов бромодомена
PH12015501929B1 (en) Substituted 2-azabicycles and their use as orexin receptor modulators
MX2016005853A (es) Compuestos de piridilo sustituidos con alquilamida utiles como muduladores de respuestas de citocinas heterodimericas interleucina 12 y 23 (il-12 e il-23) y/o interferon alfa (ifnalfa).
UA116794C2 (uk) Моноциклічна піридинова похідна
MA39189A1 (fr) Dérivés de 1h-indazole et de 1h-indole antibactériens
MX2016017405A (es) Compuestos derivados de 2-(3-piridinil)-1h-benzimidazol y medicamentos que los contienen.
PH12016500109B1 (en) Substituted pyrazolylpyrazole derivative and use of same as herbicide
CR20160082A (es) Nuevo derivado de triazina
MX2015015010A (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
MX366678B (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
ES2561674T3 (es) Antagonistas de TRPV4
IN2014CN02036A (es)
RS53054B (en) PROTEATING INHIBITORS
MX2015006930A (es) Compuestos de isoxazol amina sustituidos como inhibidores de scd1.
MX368759B (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
MX2015002705A (es) Compuestos de piridinona para usarse en terapia fotodinamica.
TH164069B (th) อนุพันธ์ไบอะโรมาติกต้านแบคทีเรีย
AR094386A1 (es) Derivados de oxazolona antibacterianos
PL405775A1 (pl) Nowy związek, zwłaszcza do stosowania jako pigment
BR112015030591A2 (pt) formas de polimorfos de maleato de icotinib e usos dos mesmos
LV14984A (lv) 2-Fenilamino-4-(piridīn-3-il)-6-perfluoralkilpirimidīni
AR083279A1 (es) Composicion de control de fitoenfermedades y su uso

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: IDORSIA PHARMACEUTICALS LTD

FG Grant or registration